Zhang Xiaoqin, Kiang Karrie Meiyee, Zhang Grace Pingde, Leung Gilberto Kakit
Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Noncoding RNA. 2015 Jun 3;1(1):69-86. doi: 10.3390/ncrna1010069.
Glioblastoma multiforme (GBM), the most common form of primary brain tumor, is highly resistant to current treatment paradigms and has a high rate of recurrence. Recent advances in the field of tumor-initiating cells suggest that glioblastoma stem cells (GSCs) may be responsible for GBM's rapid progression, treatment resistance, tumor recurrence and ultimately poor clinical prognosis. Understanding the biologically significant pathways that mediate GSC-specific characteristics offers promises in the development of novel biomarkers and therapeutics. Long non-coding RNAs (lncRNAs) have been increasingly implicated in the regulation of cancer cell biological behavior through various mechanisms. Initial studies strongly suggested that lncRNA expressions are highly dysregulated in GSCs and may play important roles in determining malignant phenotypes in GBM. Here, we review available evidence on aberrantly expressed lncRNAs identified by high throughput microarray profiling studies in GSCs. We also explore the potential functional pathways by analyzing their interactive proteins and miRNAs, with a view to shed lights on how this novel class of molecular candidates may mediate GSC maintenance and differentiation.
多形性胶质母细胞瘤(GBM)是原发性脑肿瘤最常见的形式,对当前的治疗模式具有高度抗性且复发率高。肿瘤起始细胞领域的最新进展表明,胶质母细胞瘤干细胞(GSCs)可能是GBM快速进展、治疗抗性、肿瘤复发以及最终临床预后不良的原因。了解介导GSC特异性特征的生物学重要途径为新型生物标志物和治疗方法的开发带来了希望。长链非编码RNA(lncRNAs)越来越多地通过各种机制参与癌细胞生物学行为的调控。初步研究强烈表明,lncRNA表达在GSCs中高度失调,可能在决定GBM的恶性表型中发挥重要作用。在此,我们回顾了通过高通量微阵列分析研究在GSCs中鉴定出的异常表达lncRNAs的现有证据。我们还通过分析它们的相互作用蛋白和miRNAs来探索潜在的功能途径,以期阐明这类新型分子候选物如何介导GSC的维持和分化。